Drugs / HDM2006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07377591 | Dec 2024 → Sep 2026 overdue | cancer | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HDM2006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07377591 ↗ |
| Route | Oral | “Oral administration within half an hour after a meal, QD” NCT07377591 ↗ |